Literature DB >> 10083559

Mycophenolate mofetil impairs transendothelial migration of allogeneic CD4 and CD8 T-cells.

R A Blaheta1, K Leckel, B Wittig, D Zenker, E Oppermann, S Harder, M Scholz, S Weber, A Encke, B H Markus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10083559     DOI： 10.1016/s0041-1345(98)01984-8

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  16 in total

1.  A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis.

Authors:  Elliot M Frohman; Gary Cutter; Gina Remington; Hongjiang Gao; Howard Rossman; Bianca Weinstock-Guttman; Jacqueline E Durfee; Amy Conger; Ellen Carl; Katherine Treadaway; Eric Lindzen; Amber Salter; Teresa C Frohman; Anjali Shah; Angela Bates; Jennifer L Cox; Michael G Dwyer; Olaf Stüve; Benjamin M Greenberg; Michael K Racke; Robert Zivadinov
Journal:  Ther Adv Neurol Disord       Date:  2010-01       Impact factor: 6.570

2.  Mycophenolic acid differentially impacts B cell function depending on the stage of differentiation.

Authors:  Jodi L Karnell; Fredrick G Karnell; Geoffrey L Stephens; Bhargavi Rajan; Chris Morehouse; Ying Li; Bonnie Swerdlow; Mildred Wilson; Raphaela Goldbach-Mansky; Christopher Groves; Anthony J Coyle; Ronald Herbst; Rachel Ettinger
Journal:  J Immunol       Date:  2011-08-26       Impact factor: 5.422

Review 3.  An update on the use of mycophenolate mofetil in lupus nephritis and other primary glomerular diseases.

Authors:  Alice S Appel; Gerald B Appel
Journal:  Nat Clin Pract Nephrol       Date:  2009-01-27

4.  Down-regulation of multiple low dose streptozotocin-induced diabetes by mycophenolate mofetil.

Authors:  D Maksimovic-Ivanic; V Trajkovic; D J Miljkovic; M Mostarica Stojkovic; S Stosic-Grujicic
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

5.  Brain dead donor kidneys are immunologically active: is intervention justified?

Authors:  G Vergoulas; P Boura; G Efstathiadis
Journal:  Hippokratia       Date:  2009-10       Impact factor: 0.471

6.  Alpha-1,2-mannosidase and hence N-glycosylation are required for regulatory T cell migration and allograft tolerance in mice.

Authors:  Elaine T Long; Stephanie Baker; Vanessa Oliveira; Birgit Sawitzki; Kathryn J Wood
Journal:  PLoS One       Date:  2010-01-26       Impact factor: 3.240

7.  The effect of mycophenolate mofetil on primary and secondary treatment of primary glomerulonephritis and lupus nephritis.

Authors:  Saime Paydas; Cemal Kurt; Hulya Taskapan; Mustafa Balal; Yasar Sertdemir; Irem Pembegul
Journal:  Int Urol Nephrol       Date:  2008-09-03       Impact factor: 2.370

Review 8.  Effect of mycophenolic acid in experimental, nontransplant glomerular diseases: new mechanisms beyond immune cells.

Authors:  Agnes Hackl; Rasmus Ehren; Lutz Thorsten Weber
Journal:  Pediatr Nephrol       Date:  2016-06-16       Impact factor: 3.714

9.  Mycophenolate mofetil in the treatment of lupus nephritis.

Authors:  Patrick Fk Yong; David P D'Cruz
Journal:  Biologics       Date:  2008-06

10.  Mycophenolate Mofetil in C3 Glomerulopathy and Pathogenic Drivers of the Disease.

Authors:  Fernando Caravaca-Fontán; Montserrat M Díaz-Encarnación; Laura Lucientes; Teresa Cavero; Virginia Cabello; Gema Ariceta; Luis F Quintana; Helena Marco; Xoana Barros; Natalia Ramos; Nuria Rodríguez-Mendiola; Sonia Cruz; Gema Fernández-Juárez; Adela Rodríguez; Ana Pérez de José; Cristina Rabasco; Raquel Rodado; Loreto Fernández; Vanessa Pérez Gómez; Ana I Ávila; Luis Bravo; Javier Lumbreras; Natalia Allende; Maria Dolores Sanchez de la Nieta; Eva Rodríguez; Teresa Olea; Marta Melgosa; Ana Huerta; Rosa Miquel; Carmen Mon; Gloria Fraga; Alberto de Lorenzo; Juliana Draibe; Marta Cano-Megías; Fayna González; Amir Shabaka; Maria Esperanza López-Rubio; María Ángeles Fenollosa; Luis Martín-Penagos; Iara Da Silva; Juana Alonso Titos; Santiago Rodríguez de Córdoba; Elena Goicoechea de Jorge; Manuel Praga
Journal:  Clin J Am Soc Nephrol       Date:  2020-08-19       Impact factor: 8.237
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.